Toyota Motor Corporation (Toyota) announces that it has developed the world's first neodymium-reduced, heat-resistant magnet. 

Zealand Pharma will use the proprietary peptide technology and world-leading expertise of UQ's Institute for Molecular Bioscience (IMB), as well as expertise from Flinders University in South Australia.

Oerlikon and Boeing to create standard processes for 3D-printed structural titanium aerospace.

Though revolutionary, the "molecular scissors" called CRISPR-Cas9 can't cut RNA. Scientists think NmeCas9 is the answer.